[Schizoaffective disorder].
Ikegami
Ken
K
Department of Neuropsychiatry, Kumamoto University School of Medicine.
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003937:Diagnosis, Differential; D039721:Diagnostic and Statistical Manual of Mental Disorders; D004359:Drug Therapy, Combination; D004565:Electroconvulsive Therapy; D006801:Humans; D011618:Psychotic Disorders / Q000145:classification / Q000175:diagnosis / Q000523:psychology / Q000628:therapy; D012015:Reference Standards
D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents